The World Health Organization (WHO) has unveiled a strategic framework aimed at bolstering global efforts to prevent and control mpox.

The new framework underscores the urgency of addressing the rising incidence of mpox, which poses a significant public health threat across the globe.

The disease, caused by the monkeypox virus (MPXV), causes painful rashes, enlarged lymph nodes and fever. While most people who contract the disease recover, some individuals can have more severe symptoms. The virus is transmitted from person to person through close contact, including sexual contact. There have also been reported spillovers from animals to humans in sest, central and west Africa.

Key elements of the strategic framework include enhancing surveillance systems, improving diagnostic capacities, and ensuring equitable access to vaccines and treatments. The framework emphasises a multi-faceted approach, incorporating scientific research and leveraging global collaboration to tackle the disease effectively.

Dr. Tedros Adhanom Ghebreyesus, WHO’s Director-General, highlighted the importance of global solidarity in combating mpox.

“This strategic framework is a crucial step towards ensuring that all countries, regardless of their economic status, have the tools and resources needed to prevent and control mpox,” Dr Ghebreyesus said.

The framework is part of the WHO’s proactive approach to addressing emerging infections diseases, reinforcing the need for preparedness and resilience in health systems around the world.